Search for European Projects

33 European Projects Found

Searched on 125080 European Projects

 FINISHED 

A Systems medicine approach to chronic inflammatory disease (SYSCID)

Start date: Jan 1, 2017, End date: Mar 31, 2022,

"The SYSCID consortium aims to develop a systems medicine approach for disease prediction in CID. We will focus on three major CID indications with distinct characteristics, yet a large overlap of their molecular risk map: inflammatory bowel disease, systemic lupus erythematodes and rheumatoid arthritis. We have joined 15 partners from major cohorts and initiatives in Europe (e.g.IHEC, ICGC, Twins ...
Read Project

 16

 FINISHED 

GALAXY: Gut-and-liver axis in alcoholic liver fibrosis (GALAXY)

Start date: Jan 1, 2016, End date: Dec 31, 2021,

Alcohol overuse is an important societal challenge with annual healthcare costs of over €22 billion in Europe. Alcohol is the main cause of liver cirrhosis, which is the 5th and 7th most common cause of life years lost in respectively Eastern and Western Europe. Cirrhosis is considered irreversible but its precursor, liver fibrosis, is reversible when detected before disease progression. GALAXY pr ...
Read Project

 12

 FINISHED 

The European network for observing our changing planet (ERA-PLANET)

Start date: Feb 1, 2016, End date: Jan 31, 2021,

In the last decade a significant number of projects and programmes in different domains of environmental monitoring and Earth observation have generated a substantial amount of data and knowledge on different aspects related to environmental quality and sustainability. Big data generated by in-situ or satellite platforms are being collected and archived with a plethora of systems and instruments m ...
Read Project

 38

 FINISHED 

Translational Research Network in Prostate Cancer (TransPot)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

The Translational Research Network for Prostate Cancer (TransPot) program adopts an innovative, multidisciplinary approach, providing highly sought-after, effective solutions for incurable prostate cancer (PC).The TransPot scientific objective is to obtain an unmatched depth of molecular, mechanistic and informatics systems-level disease understanding in order to improve the prognosis and treatmen ...
Read Project

 11

 FINISHED 

Big data against childhood Obesity (BigO)

Start date: Dec 1, 2016, End date: Nov 30, 2020,

Childhood and adolescent obesity is a major global and European public health problem. Currently, public actions are detached from local needs, mostly including indiscriminate blanket policies and single-element strategies, limiting their efficacy and effectiveness. The need for community-targeted actions has long been obvious, but the lack of monitoring and evaluation framework and the methodolog ...
Read Project

 14

 FINISHED 

A miniature Bio-photonics Companion Diagnostics platform for reliable cancer diagnosis and treatment monitoring. (BIOCDx)

Start date: Jan 1, 2017, End date: Dec 31, 2019,

Current diagnostic options for cancer treatment monitoring rely on imaging techniques and cannot guarantee proper assessment of therapeutic response. This project aims to develop a disruptive Point of Care (PoC) device for cancer early diagnosis and treatment monitoring as a companion diagnostics tool. One of the scientific breakthroughs of this project is the development of a “cancer stem cells” ...
Read Project

 8

 FINISHED 

PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform (PRETREAT)

Start date: Jan 1, 2016, End date: Dec 31, 2019,

Cardiovascular disease (VD) is the leading cause of mortality and morbidity in Europe and worldwide. The objective of the PRETREAT consortium is to generate a joint SME/academic European preclinical platform for providing services for detection of VD and drug development. This platform will combine the use of urinary and/or blood peptidomics in humans and in preclinical animal models of VD, togeth ...
Read Project

 6

 FINISHED 

Coordinated Research Infrastructures Building Enduring Life-science services (CORBEL)

Start date: Sep 1, 2015, End date: Aug 31, 2019,

The social and economic challenges of ageing populations and chronic disease can only be met by translation of biomedical discoveries to new, innovative and cost effective treatments. The ESFRI Biological and Medical Research Infrastructures (BMS RI) underpin every step in this process; effectively joining scientific capabilities and shared services will transform the understanding of biological m ...
Read Project

 39

 FINISHED 

implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC (ADOPT BBMRI-ERIC)

Start date: Oct 1, 2015, End date: Sep 30, 2018,

"BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure - European Research Infrastructure Consortium, aims to establish, operate and develop a Pan-European distributed research infrastructure in order to facilitate the access to biological resources as well as facilities and to support high quality biomolecular and biomedical research. The ADOPT BBMRI-ERIC proposal aims at ...
Read Project

 22

 FINISHED 

Multimodal Imaging of rare Synucleinopathies (MultISyn)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

Despite remarkable progress in the understanding of the molecular pathogenesis of neurodegenerative diseases (NDD), no causative or disease-modifying treatment is currently available. Aggregation of misfolded proteins are thought to play a crucial role in the pathogenesis, but attempts to exploit this knowledge for novel treatments have not been successful. Also, pathogenetically relevant biomarke ...
Read Project

 9

 FINISHED 

Coordinating and integRating state-of-the-art Earth Observation Activities in the regions of North Africa, Middle East, and Balkans and Developing Links with GEO related initiatives towards GEOSS (GEO-CRADLE)

Start date: Feb 1, 2016, End date: Jul 31, 2018,

GEO-CRADLE brings together key players representing the whole (Balkans, N. Africa and M. East) region and the complete EO value chain with the overarching objective of establishing a multi-regional coordination network that will (i) support the effective integration of existing EO capacities (space/air-borne/in-situ monitoring networks, modelling and data exploitation skills, and past project expe ...
Read Project

 20

 FINISHED 

Transferring NOn autonomous cell degeneration models between EU and USA for development of effective therapies for Motor Neuron Diseases (MND) (NO-MND)

Start date: Feb 1, 2014, End date: Jan 31, 2018,

"Amyotrophic lateral sclerosis (ALS) and Spinal Muscular Atrophy (SMA) are fatal diseases characterized by selective degeneration of motor neurons without any effective treatment. Non-neuronal cells like astrocytes play a key role in the pathogenesis of ALS and SMA. Understanding the mechanisms of cell death caused by non-neuronal cells is a major research target and it has been proposed that tran ...
Read Project

 3

 FINISHED 

Micro-ring resonator-based biophotonic system for food analysis (BIOFOS)

Start date: Nov 1, 2013, End date: Oct 31, 2016,

Current methodologies for detection of food contamination based on heavy analytical tools cannot guarantee a safe and stable food supply. The reasons are the complexity, the long time-to-result (2-3 days) and the cost of these tools, which limit the number of samples that can be practically analyzed at food processing and storage sites. The need for screening tools that will be still reliable but ...
Read Project

 12

 FINISHED 

Molecular Medicine for Bladder Cancer (BCMolMed)

Start date: Oct 1, 2012, End date: Sep 30, 2016,

BCMolMed integrates complementary and multi-disciplinary expertise of two main (research-intensive SME-academia) and five associate partners with the objective to generate a state of the art training platform on application-oriented biomarker research and systems biology. Special emphasis is placed on the efficient employment of proteomics and bioinformatics techniques to clinical research, and un ...
Read Project

 3

 FINISHED 

Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction (TransBioBC)

Start date: Sep 1, 2013, End date: Aug 31, 2016,

Currently, clinical diagnosis and monitoring of bladder cancer (BC) relies on invasive, highly costly cystoscopy. Additionally, due to high recurrence rates BC treatment is associated with frequent follow-up of patients, making BC one of the most costly types of cancer in terms of management cost. Thus there is a clear clinical need for the development of new approaches for early detection of recu ...
Read Project

 5

 FINISHED 

hERG related risk assessment of botanicals (HERGSCREEN)

Start date: Mar 1, 2012, End date: Feb 29, 2016,

The main goal of this project is the establishment of a network between European, South American, North American and South African educational and research entities. This attempt will be based on an innovative scientific project aiming towards the identification of hERG (human Ether-à-go-go Related Gene) channel blockers in commonly consumed botanicals and supplements. Blocking these ion channels ...
Read Project

 6

 FINISHED 

Immune mechanisms of osteopontin-mediated protection in allergic airway disease (OPN-IMMUNOREGULATION)

Start date: Dec 1, 2009, End date: Nov 30, 2015,

In allergic asthma, an important health problem, disease is driven by allergen-specific Th2 immune responses. Differentiation of Th2 cells depends on their early interactions with antigen presenting cells, such as dendritic cells (DCs), and cytokines are crucial for this process. Osteopontin (Opn) was originally identified as an important cytokine for Th1 immunity and autoimmunity. Our group recen ...
Read Project

 2

 FINISHED 

Modulating motor output in the mammalian spinal cord (MODULATIONSPINALCORD)

Start date: Sep 1, 2011, End date: Aug 31, 2015,

The executive component of movement – the task of determining which muscles to activate, how intensely, and for how long – depends on neural circuits located in the spinal cord. At the core of these circuits are local interneurons (INTs) that regulate the pattern and frequency of motor neuron (MN) firing. Spinal motor activity is shaped by a combination of amino acid mediated excitation and inhibi ...
Read Project

 2

 FINISHED 

The emergence of bioenergetic diversity in prokaryotes (EBioDiP)

Start date: Mar 1, 2013, End date: Feb 28, 2015,

Prokaryotes are characterised by an amazing metabolic diversity, which allows them to persist in diverse and often extreme habitats. Some are able to use light or organic matter to harvest energy and fix carbon, while others utilise chemo- or lithotrophic modes which use theredox potential of molecules found in their particular environment to harness energy for their survival. Molecular evolution ...
Read Project

 2

 FINISHED 

The role of mRNA-processing bodies in ageing (PAGE)

Start date: Sep 1, 2008, End date: Aug 31, 2014,

Recently, we and others have revealed that, in the nematode Caenorhabditis elegans, reduction of protein synthesis rates in somatic cells extends lifespan. Based on this, we postulate that the molecular factors and mechanisms that control the mRNA metabolism in post-mitotic cells are critical determinants of ageing. This project will validate this hypothesis using C. elegans as main model system, ...
Read Project

 2

 FINISHED 

MicroEncapsDelivery

Start date: Sep 1, 2012, End date: Aug 31, 2014,

In this multidisciplinary research proposal we aim to develop a new therapeutic platform for hepatocellular carcinoma (HCC). HCC is the third leading cause of cancer death worldwide with a death rate greater than 600,000 persons annually. Currently the main curative treatments include resection, liver transplantation, or percutaneous local ablative treatment. However, all these approaches are prim ...
Read Project

 2

 FINISHED 

Development and Neuromodulation of Intrinsic Cortical Activity (INTRICA)

Start date: Jul 1, 2010, End date: Jun 30, 2014,

"We propose to study intrinsic cortical network activity in-vitro. It is already known that the cerebral cortex, both in-vivo and in-vitro, produces spontaneous patterns of electrical activity independently of extrinsic inputs. These consist of network-induced prolonged depolarizations & action potentials (UP states), alternating with periods of synaptic withdrawal, membrane hyperpolarization and ...
Read Project

 2

 FINISHED 

IMPROVEMENT OF TOOLS AND PORTABILITY OF MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS AS APPLIED TO CHRONIC KIDNEY DISEASE (PROTOCLIN)

Start date: May 15, 2010, End date: May 14, 2014,

The number of patients with chronic kidney disease (CKD) is increasing steadily due to extended life expectancy, long lasting diabetes and obesity. Early unambiguous detection of patients at risk is both a clinical and scientific challenge. Capillary electrophoresis coupled to mass spectrometry (CE-MS), developed by Mosaiques Diagnostics (MD, SME, Germany), has been shown to be an excellent tool f ...
Read Project

 4

 FINISHED 

Targeting the mutated PI3Kα isoform for the development of novel anti-cancer agents (Comput Drug Design)

Start date: May 1, 2010, End date: Apr 30, 2014,

The application of rational drug design is proven to be more efficient than the traditional way of drug discovery since it aims to understand the molecular basis of a disease. The aim of this project is to deactivate the mutated cancerous PI3Kα protein with small molecule inhibitors. It was recently established that PIK3CA, the gene encoding the catalytic p110α subunit of PI3K, is frequently mutat ...
Read Project

 2

 FINISHED 

Academic-Industrial Training Network on Alpha-Synuclein-related Brain Diseases (NEURASYNC)

Start date: Nov 1, 2009, End date: Oct 31, 2013,

"Parkinson’s Disease (PD) is the second most common neurodegenerative disorder. It is characterized pathologically by the accumulation of aggregated conformations of the presynaptic protein alpha-synuclein (ASYN) in cytoplasmic inclusions termed Lewy Bodies (LBs). Furthermore, aberrant aggregated species of ASYN accumulate in various disease states, such as Multiple System Atrophy, Diffuse LB Dise ...
Read Project

 11

 FINISHED 

European Project on Mendelian Forms of Parkinson’s Disease (MEFOPA)

Start date: Apr 1, 2010, End date: Sep 30, 2013,

"The Collaborative Project on Mendelian Forms of Parkinson’s Disease (MEFOPA) will bring together the major groups in Europe with a track-record in basic and clinical research on rare Mendelian forms of Parkinson’s disease (PD) in order to identify and validate relevant disease-related molecular pathways, drug-targets and biomarkers for disease susceptibility and progression.. Over the last years ...
Read Project

 27

 FINISHED 

DATA REPOSITORIES AND COMPUTATIONAL INFRASTRUCTURE FOR ENVIRONMENTAL AND CLIMATE STUDIES IN THE EASTERN MEDITERRANEAN (DARECLIMED)

Start date: Feb 1, 2011, End date: Jul 31, 2013,

"The Mediterranean and Middle East, with a combined total population of more than 400 million people, are characterized by strong environmental gradients, climate extremes and diverse economic, social and cultural identities. It is expected that throughout the 21st century the region will experience substantial adverse climate changes and face major challenges in energy demand and supply, as well ...
Read Project

 8

 FINISHED 

Translating basic research findings in major human diseases (TranSMed)

Start date: Jan 1, 2010, End date: Jun 30, 2013,

Improvement of human health requires translation of the basic research discoveries into practical applications for human disease, including biomarker identification, novel clinical tools, and medications. The scope of TranSMed is to support the development of a center of excellence in the EU target area of “translational research for major human diseases”, in the convergence region of Attica, Gree ...
Read Project

 2

 FINISHED 

Markers of prenatal metabolic plasticity and assessment of their reversibility by postnatal interventions (Metabolic Plasticity)

Start date: Jul 1, 2010, End date: Jun 30, 2013,

Inactivity and nutritional aberrations result in an expanding population of individuals with compromised metabolic function including obesity and insulin resistance. From this pool of individuals an increasing percentage develops overt diabetes leading to vast personal and social burden. Natural interventions are beneficial and exercise accompanied by weight loss can reverse insulin resistance, at ...
Read Project

 2

 FINISHED 

Stem Cells and Cancer Stem Cells in Mouse Mammary Glands (MG stem)

Start date: May 25, 2009, End date: May 24, 2013,

It is thought that, although cancer stem cells are a small minority in the tumor cell population, they can escape the toxicity of drugs used for treatment, as they are relatively quiescent, i.e. chemotherapy can lead effectively to remission, but not frequently to a cure. An important question that cannot be answered at present and should certainly be addressed is whether a therapeutic window can ...
Read Project

 2

 FINISHED 

Novel Interleukins for immunotherapy of Asthma (NILTHERA)

Start date: Jan 1, 2010, End date: Dec 31, 2012,

"Allergies are increasing in incidence at an alarming rate. One in three Europeans suffers from an allergy and one in ten children suffers from asthma. From the E.U. perspective, the cost from allergies in terms of health care and absenteeism from work is estimated at 45 billion euros a year. Despite prioritization of allergies and asthma in recent E.U. Framework Programme activities, there are ma ...
Read Project

 2

 FINISHED 

Integrated approaches to study gene regulation during cellular differentiation (InteGeR)

Start date: Jan 1, 2009, End date: Dec 31, 2012,

Cellular differentiation from stem cells to fully functional mature cells is a multi step process executed by complex transcription programs. Once differentiated, cells must faithfully maintain their identity through cellular memory mechanisms. The utilisation of genetic information stored in linear DNA sequence occurs within the three dimensional context of chromatin, chromosomes and the nucleus, ...
Read Project

 9

 FINISHED 

Multicentre discovery of breast cancer biomarkers (CANOMICS)

Start date: Aug 1, 2010, End date: Jul 31, 2012,

"Breast cancer is the most common cause of death from cancer among European women, and over half of the worldwide breast cancer related mortalities occur in the developing world. Despite improvements in surgical techniques and chemoradiotherapy, the ability to cure patients with breast cancer remains limited and five year survival for patients with advanced disease is dismal. Expression profiling ...
Read Project

 4